Cite
HARVARD Citation
Gluz, O. et al. (2020). Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple‐negative early breast cancer: Primary translational analysis of the WSG‐ADAPT‐TN trial. International journal of cancer. 146 (1), pp. 262-271. [Online].